Key information

🔎 Fund Overview

Oventus Medical Ltd. develops oral appliances for the treatment of obstructive sleep disordered and snoring. The company is headquartered in Brisbane, Queensland. The company went IPO on 2016-07-19. The firm is commercializing a treatment platform for obstructive sleep apnea (OSA) and snoring. The Company’s O2Vent devices are designed for any patient that is deemed appropriate for oral appliance therapy, but especially beneficial for the many people that suffer with nasal congestion, obstruction and mouth breathing. The Company’s product offerings include Oventus O2Vent Optima, O2Vent Optima, the ExVent and O2Vent Optima Mini. The Oventus O2Vent Optima product range provides relief to people who suffer snoring or mild to moderate OSA, and those who are unable to tolerate continuous positive airway pressure (CPAP) therapy. Its O2Vent Optima is an oral appliance, which features an integrated airway, using its own airway technology to treat the upper airway. The company provides an uninterrupted airflow during sleep, as well as when a patient experiences nasal obstruction.